MRC Human Immunology Unit
We are a leading research centre in human immunology and the development of treatments against infectious diseases, cancer, allergy and autoimmune disease.
Chapman TP. et al, (2019), Front Immunol, 10
Pinkwart K. et al, (2019), J Biol Chem, 294, 12599 - 12609
Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses.
Abd Hamid M. et al, (2019), Cancer Immunol Res
Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
Huang K-YA. et al, (2019), Nat Microbiol, 4, 306 - 315
Corridoni D. et al, (2019), Front Immunol, 10
PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection.
Rigby RE. et al, (2019), Sci Rep, 9